Matches in Wikidata for { <http://www.wikidata.org/entity/Q64043216> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q64043216 description "clinical trial" @default.
- Q64043216 description "ensayu clínicu" @default.
- Q64043216 description "klinisch onderzoek" @default.
- Q64043216 description "клінічне випробування" @default.
- Q64043216 description "կլինիկական փորձարկում" @default.
- Q64043216 name "Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y" @default.
- Q64043216 type Item @default.
- Q64043216 label "Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y" @default.
- Q64043216 prefLabel "Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y" @default.
- Q64043216 P1050 Q64043216-5B42B9A0-F9B6-4846-9230-2D2751F643E0 @default.
- Q64043216 P1050 Q64043216-7EEA59FF-2E49-4324-B8FE-5C89171AF126 @default.
- Q64043216 P1132 Q64043216-2DFD7E3D-CFAA-44FD-8C0A-6355076FF644 @default.
- Q64043216 P1476 Q64043216-B585736C-FA7F-47F3-9106-2AA1CF35368D @default.
- Q64043216 P17 Q64043216-300D6A7A-6A61-470A-9016-0E12988480F1 @default.
- Q64043216 P2899 Q64043216-2DFCD954-238E-4AA6-968F-F99252E4C1D1 @default.
- Q64043216 P3098 Q64043216-F3150B45-7A35-4A4B-8C78-B7C3EDFD3040 @default.
- Q64043216 P31 Q64043216-5E6936A9-9286-4D54-8F8A-466D34F21E38 @default.
- Q64043216 P4135 Q64043216-4A8A7E49-AD43-4AD3-9979-21F1657BC0C5 @default.
- Q64043216 P580 Q64043216-CF04A17D-BFFF-4E4C-88E3-EF4191B25D30 @default.
- Q64043216 P582 Q64043216-45B176ED-EE3B-491B-AA32-76EE5F775208 @default.
- Q64043216 P6099 Q64043216-02FF7A05-F9BA-4039-BD02-BCFBD98656E0 @default.
- Q64043216 P8363 Q64043216-FA38A7B1-334E-44C4-8765-AA55BDAAF961 @default.
- Q64043216 P859 Q64043216-9ECE79A4-21DD-4332-A032-7CCCCA39838A @default.
- Q64043216 P1050 Q131742 @default.
- Q64043216 P1050 Q6853 @default.
- Q64043216 P1132 "+160" @default.
- Q64043216 P1476 "Study Comparing the Immunogenicity and Reactogenicity of Different Formulations of GSK Bio's HBV-MPL Vaccine Injected as a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in Healthy Adults Aged 19-40 Years" @default.
- Q64043216 P17 Q40 @default.
- Q64043216 P2899 "+19" @default.
- Q64043216 P3098 "NCT00698906" @default.
- Q64043216 P31 Q30612 @default.
- Q64043216 P4135 "+40" @default.
- Q64043216 P580 "1997-06-01T00:00:00Z" @default.
- Q64043216 P582 "1998-02-01T00:00:00Z" @default.
- Q64043216 P6099 Q42824440 @default.
- Q64043216 P8363 Q78089383 @default.
- Q64043216 P859 Q212322 @default.